Literature DB >> 21417030

[COX-2 regulation of prostaglandins in synaptic signaling].

Hong-Wei Yang1.   

Abstract

Cyclooxygenase-2 (COX-2) is a rate-limiting enzyme converting arachidonic acid to prostaglandins (PGs), which is a key messenger in traumatic brain injury- and ischemia-induced neuronal damage and in neuroinflammation. COX-2 is implicated in the pathogeneses of neurodegenerative diseases. Growing evidence implies that the contribution of COX-2 to neuropathology is associated with its involvement in synaptic alteration. Elevation or inhibition of COX-2 has been shown to enhance or suppress excitatory glutamatergic neurotransmission and long-term potentiation (LTP). These events are mainly mediated via PGE2, the predominant reaction product of COX-2, and the PGE2 subtype 2 receptor (EP2). Thus, elucidation of COX-2 in synaptic signaling may provide a mechanistic basis for designing new drugs aimed at preventing, treating or alleviating neuroinflammation-associated neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 21417030

Source DB:  PubMed          Journal:  Sheng Li Ke Xue Jin Zhan        ISSN: 0559-7765


  2 in total

1.  Release-active dilutions of diclofenac enhance anti-inflammatory effect of diclofenac in carrageenan-induced rat paw edema model.

Authors:  Sachin S Sakat; Kamaraj Mani; Yulia O Demidchenko; Evgeniy A Gorbunov; Sergey A Tarasov; Archna Mathur; Oleg I Epstein
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

2.  Decreased expression level and DNA-binding activity of specificity protein 1 via cyclooxygenase-2 inhibition antagonizes radiation resistance, cell migration and invasion in radiation-resistant lung cancer cells.

Authors:  Ruijun Liu; Qiang Tan; Qingquan Luo
Journal:  Oncol Lett       Date:  2018-06-28       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.